Bayesian Capital Management, LP Omeros Corp Transaction History

Bayesian Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$12.21 - $16.99 $246,642 - $343,197	-20,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$9.03 - $19.72 $182,406 - $398,344	20,200 New	20,200 $270,000
Q1 2018 May 15, 2018	SELL	$9.0 - $20.16 $112,500 - $252,000	-12,500 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$13.26 - $22.86 $165,750 - $285,750	12,500	12,500 $243,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $378M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.